4//SEC Filing
Donenberg Phillip B. 4
Accession 0001415889-25-015573
CIK 0001806310other
Filed
Jun 3, 8:00 PM ET
Accepted
Jun 4, 4:15 PM ET
Size
7.4 KB
Accession
0001415889-25-015573
Insider Transaction Report
Form 4
DONENBERG PHILIP B
Director
Transactions
- Award
Stock Option (right to buy)
2025-06-02+113,246→ 113,246 totalExercise: $2.79Exp: 2035-06-02→ Common Stock (113,246 underlying) - Award
Common Stock
2025-06-02+56,623→ 219,954 total
Footnotes (2)
- [F1]Represents a restricted stock unit ("RSU") award. The RSUs will vest on the earlier of June 2, 2026 or the next annual stockholders meeting, subject to the Reporting Person's continued service as a director through the applicable vesting date.
- [F2]The shares vest on the earlier of June 2, 2026 or the next annual stockholders meeting, subject to the Reporting Person's continued service as a director through the applicable vesting date.
Documents
Issuer
Taysha Gene Therapies, Inc.
CIK 0001806310
Entity typeother
Related Parties
1- filerCIK 0001238120
Filing Metadata
- Form type
- 4
- Filed
- Jun 3, 8:00 PM ET
- Accepted
- Jun 4, 4:15 PM ET
- Size
- 7.4 KB